passage bio stock forecast

In other news major shareholder Orbimed Advisors Llc acquired 369100 shares of Passage Bio stock in a transaction on Thursday January 20th. Find the latest Passage Bio Inc.

Passage Bio Inc Share Price Usd0 0001

The reported 095 EPS for the quarter missing analysts consensus estimates of 084 by 011.

. The 7 analysts offering 12-month price forecasts for Passage Bio Inc have a median target of 1600 with a high estimate of 3400 and a low estimate of 400. Stock Market Articles Youth Investment Group. Investors can use this forecasting interface to forecast Passage Bio historical stock prices and determine the direction of Passage Bios future trends based on various well-known forecasting models.

See Passage Bio Inc. PASG one year forecast. Smartmarket reports provide research on emerging trends that are impacting and transforming the construction and building industry.

Passage Bio undertakes no obligation to publicly update any forward-looking statement whether written or oral that may be made from time to time whether as a result of new information future developments or otherwise. The stock was bought at an average cost of 542 per. The Score for PASG is 28 which is 44 below its historic median score of 50 and infers higher risk than normal.

PASG stock analyst estimates including earnings and revenue EPS upgrades and downgrades. Passage Bio undertakes no obligation to publicly update any forward-looking statement whether written or oral that may be made from time to time whether as a result of new information future developments or otherwise. Stuart Henderson Passage Bio 267-866-0114 shenderson.

S revenue in 2022 is 0. Passage Bio last announced its earnings data on March 3rd 2022. Passage Bio Stock Forecast.

Passage Bio has generated 348 earnings per share over the last year 348 diluted earnings per share. If you had invested in Passage BIO stock at 2220 your return over the last 2 years would have been -8608 for an annualized return of -6269 not including any dividends or. It develops PBGM01 which utilizes a proprietary AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase Ã-gal for infantile GM1.

Passage Bio Stock Symbol Avro Stock Forecast Price News Avrobio Marketbeat. Passage Bio price history PASG 1 day chart with daily weekly monthly prices and market capitalizations. PASG share price prediction for 2022 2023 2024 2025 2026 and 2027.

Pasg stock price news historical charts analyst ratings and financial information from wsj. Investors can use this forecasting interface to forecast Passage Bio historical stock prices and determine the direction of Passage Bios future trends based on various well-known forecasting models. The stocks fifty day simple moving average is 444 and its 200-day.

The current Passage Bio Inc share price is 975. Is Passage Bio Inc Stock Undervalued. Delivers machine learning based share price forecast.

Passage Stock Forecast is based on your current time horizon. Earnings for Passage Bio are expected to grow in the coming year. For further information please contact.

Passage Bio stock monthly and weekly forecasts. However solely looking at the historical price movement is usually misleading. Passage Bio Inc Stock - Passage Bio Stock Forecast Down To 0 000001 Usd Pasg Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis For 2022 we think every investor needs to know about this ultimate buy.

Shares of Passage Bio were trading at 338 as of March 01. Stuart Henderson Passage Bio 267-866-0114 shenderson. Shares of NASDAQPASG opened at 295 on Friday.

PASG stock quote history news and other vital information to help you with your stock trading and investing. Passage BIO stock was originally listed at a price of 2220 in Feb 28 2020. Passage Stock Forecast is based on your current time horizon.

However solely looking at the historical price movement is usually misleading. However solely looking at the historical price movement is usually misleading. Passage Bio Inc Stock Forecast.

On average 2 Wall Street analysts forecast PASGs revenue for 2025 to be 874655252 with the lowest PASG revenue forecast at 544012764 and the highest PASG revenue forecast at 1205297740. PASG is currently trading in the 20-30 percentile range relative to its historical Stock Score levels. Passage Bio Stock Forecast - Daily Balance Of Power.

Has a 52-week low of 257 and a 52-week high of 2212. For further information please contact. Passage Bio Inc a genetic medicines company develops transformative therapies for rare monogenic central nervous system CNS diseases.

Investors can use this forecasting interface to forecast Passage Bio historical stock prices and determine the direction of Passage Bios future trends based on various well-known forecasting models. Over the last 52-week period shares are down 8296.

Wprbtxed3fgurm